Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
2
×
Tags
biotech
boston blog main
boston top stories
crispr
2
×
gene editing
life sciences
2
×
national blog main
2
×
2025
ad-comm
affimed
akcea therapeutics
allergan
allogene therapeutics
amicus therapeutics
approval
apremilast
base editing
bio
biogen
biome
blueprint medicineas
boston
boulder/denver blog main
boulder/denver top stories
briefing docs
car-t
celgene
cervical cancer
clinical study
clinical trial
clinical trials
commissioner
crispr therapeutics
cybersecurity
cynthia collins
democrats
detection
detroit blog main
detroit top stories
digital health
What
crispr
2
×
million
2
×
allergan
allogene
bio
blessing
bosley
cancer
ceo
check
clinical
cusp
depart
diversity
editas
editing
experimental
gene
hot
humans
immunotherapy
investors
ipo
juno
katrine
medicine
nearly
new
partner
regulatory
remains
roundup
shares
snapped
test
therapeutics
therapy
ticket
trial
utero
Language
Current search:
crispr
×
crispr
×
" national blog main "
×
photo
×
" life sciences "
×
million
×
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
